The country’s number two laboratory testing provider, LabCorp (Burlington, NC), has entered into a definitive agreement to acquire Tandem Labs Inc., a Salt Lake City-based bioanalytical contract research organization (CRO) working with pharmaceutical and biotechnology companies on discovery, preclinical, and clinical drug development programs. Tandem Labs—which also has facilities in West Trenton, New Jersey, and Woburn, Massachusetts—will operate under LabCorp’s Esoterix clinical trials group and will maintain its existing name, along with current employee and management structure. Financial terms of the transaction were not disclosed.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

February 2008 - Table of Contents

LIR February 2008 (full PDF issue)

Global Lab M&A Tops $3.9 Billion, $3.1 Billion in U.S. for ’07

Sonic Takes Over Labs in New Jersey, Tennessee

Carilion Labs Acquires Innovative Pathology Services

CMS Gives Pathologists Incentives for Quality Reporting

LabCorp’s Growth Focused on Companion Dx, Managed Care Contracts

U.S. Lab M&A Climbs to $3.1B in 2007

PAML’s Newest Joint Venture Focused on Capturing Salt Lake City Outreach Market

Lab Stocks Down 5% Over Past 5 Weeks, 1% So Far in '08

Molecular Diagnostics 2008 Is a Must-Attend Event